At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Molecular and Clinical Biology of von Willebrand Disease Study

Clinical Trial Title: 
Molecular and clinical biology of von Willebrand disease.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Lisa Boggio, MD
Clinical Trial Protocol Description: 

This research study will compare bleeding symptoms (or lack of bleeding symptoms) to each of the following:

  1. Routine laboratory tests used to diagnosed von Willebrand disease (VWD).
  2. New genetic or specialized tests of how von Willebrand Factor (VWF) works.
  3. Determine if other genes or proteins might cause you to have (or not have) bleeding symptoms or abnormal VWD laboratory tests results.

The study will also verify if patients have VWD.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have VWD.
  • Are at least 2 years of age.

This is a partial list of elgibility requirements.

Clinical Trial Area: 
Blood Disorders and Hematologic Cancers
Contact Phone: 
(312) 942-3034
Contact Name: 
Lisa Boggio, MD